Fallopian tube origin of supposed ovarian high-grade serous carcinomas

Clinics

Volumn 66, Issue 1, 2011, Pages 73-76

  Diniz, Patricia Martini ^a   Carvalho, Jesus Paula ^a   Baracat, Edmund Chada ^a   Carvalho, Filomena M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

BRCA1; BRCA2; Fallopian tube carcinoma; Ovarian cancer; Peritoneal cancer; Serous carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOMA; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; PELVIS TUMOR; RETROSPECTIVE STUDY; TUMOR SUPPRESSOR GENE; UTERINE TUBE; UTERINE TUBE TUMOR;

ADULT; AGED; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FALLOPIAN TUBE NEOPLASMS; FALLOPIAN TUBES; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PELVIC NEOPLASMS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79952926778     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000100013     Document Type: Article

References (25)

1. Winter WE 3rd, Maxwell GL, Tian C, Sundborg MJ, Rose GS, Rose PG, et al. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2008;26:83-9, doi: 10.1200/JCO.2007.13.1953.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60, doi: 10.3322/caac.20073.
3. Sogaard M, Kjaer SK, Gayther S. Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention. Acta Obstet Gynecol Scand. 2006;85:93-105, doi: 10.1080/00016340500324621.
4. Seidman JD, Horkayne-Szakaly I, Haiba M, Boice CR, Kurman RJ, Ronnett BM. The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int J Gynecol Pathol. 2004;23:41-4, doi: 10.1097/01.pgp.0000101080.35393.16.
5. Vang R, Shih Ie M, Kurman RJ. Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol. 2009;16:267-82, doi: 10.1097/PAP.0b013e3181b4fffa.
6. Gershenson DM, Sun CC, Lu KH, Coleman RL, Sood AK, Malpica A, et al. Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary. Obstet Gynecol. 2006;108:361-8, doi: 10.1097/01.AOG.0000227787. 24587.d1.
7. Kurman RJ, Shih Ie M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34:433-43, doi: 10.1097/PAS.0b013e3181cf3d79.
8. Shih M, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004;164:1511-18.
9. Singer G, Oldt R 3rd, Cohen Y, Wang BG, Sidransky D, Kurman RJ, et al. Mutations in BRAF and KRAS characterize the development of lowgrade ovarian serous carcinoma. J Natl Cancer Inst. 2003;95:484-6, doi: 10.1093/jnci/95.6.484.
10. Singer G, Stohr R, Cope L, Dehari R, Hartmann A, Cao DF, et al. Patterns of p53 mutations separate ovarian serous borderline tumors and lowand high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation. Am J Surg Pathol. 2005;29:218-24, doi: 10.1097/01.pas. 0000146025.91953.8d.
11. Singer G, Kurman RJ, Chang HW, Cho SK, Shih Ie M. Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol. 2002;160:1223-8.
12. Sieben NL, Macropoulos P, Roemen GM, Kolkman-Uljee SM, Jan Fleuren G, Houmadi R, et al. In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours. J Pathol. 2004;202:336-40, doi: 10.1002/path.1521.
13. Folkins AK, Jarboe EA, Roh MH, Crum CP. Precursors to pelvic serous carcinoma and their clinical implications. Gynecol Oncol. 2009;113:391-6, doi: 10.1016/j.ygyno.2009.01.013.
14. Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 2007;211:26-35, doi: 10.1002/path.2091.
15. Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 2006;30:230-6, doi: 10.1097/01.pas.0000180854.28831.77.
16. Crum CP, Drapkin R, Miron A, Ince TA, Muto M, Kindelberger DW, et al. The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol. 2007;19:3-9, doi: 10.1097/GCO. 0b013e328011a21f.
17. Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res. 2007;5:35-44, doi: 10.3121/cmr.2007.702.
18. Crum CP, Xian W. Bringing the p53 signature into focus. Cancer. 2010;116:5119-21.
19. Nikrui N, Duska LR. Fallopian tube carcinoma. Surg Oncol Clin N Am. 1998;7:363-73.
20. Gadducci A, Biglia N, Cosio S, Sismondi P, Genazzani AR. Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy. Gynecol Endocrinol. 2010;26:568-77, doi: 10.3109/09513590.2010.487609.
21. Salvador S, Gilks B, Kobel M, Huntsman D, Rosen B, Miller D. The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int J Gynecol Cancer. 2009;19:58-64, doi: 10.1111/IGC.0b013e318199009c.
22. Carlson JW, Miron A, Jarboe EA, Parast MM, Hirsch MS, Lee Y, et al. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol. 2008;26:4160-5, doi: 10.1200/JCO.2008.16.4814.
23. Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol. 2007;31:161-9, doi: 10.1097/01.pas.0000213335.40358.47.
24. Mehrad M, Ning G, Chen EY, Mehra KK, Crum CP. A pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube. Adv Anat Pathol. 2010;17:293-302, doi: 10. 1097/PAP.0b013e3181ecdee1.
25. Carvalho JP, Carvalho FM. Is Chlamydia-infected tubal fimbria the origin of ovarian cancer? Med Hyp. 2008;71:690-3, doi: 10.1016/j.mehy. 2008.06.028.